Athira Pharma Inc logo

Athira Pharma Inc

$ 4.00 +0.1 (+2.56%) 03:47 PM EST
P/E:
At Loss
P/B:
0.49
Market Cap:
$ 148.66M
Enterprise V:
$ -114.89M
Volume:
453.84K
Avg Vol (2M):
1.40M
Volume:
453.84K
Market Cap $:
148.66M
PE Ratio:
At Loss
Avg Vol (2-Month):
1.40M
Enterprise Value $:
-114.89M
PB Ratio:
0.49
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download Tutorials

Business Description

Athira Pharma Inc
NAICS : 541714 SIC : 2833
18706 North Creek Parkway, Suite 104, Bothell, WA, USA, 98011
Description
Athira Pharma Inc is a biotechnology company focused on developing small molecules to restore neuronal health and stop neurodegeneration. The company is developing treatments for Alzheimer's disease and Parkinson's disease.
Name Current Vs Industry Vs History
Cash-To-Debt 142.37
Equity-to-Asset 0.97
Debt-to-Equity 0.01
Debt-to-EBITDA -0.03
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 0
Distress
Grey
Safe
Beneish M-Score 0
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -21.5
3-Year EPS without NRI Growth Rate -21.8
3-Year FCF Growth Rate -18.6

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 68.71
9-Day RSI 60.61
14-Day RSI 50.26
6-1 Month Momentum % -66.18
12-1 Month Momentum % -65.01

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 28.42
Quick Ratio 28.42
Cash Ratio 27.82

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -82.1

Profitability Rank

Name Current Vs Industry Vs History
ROE % -20.01
ROA % -19.45
ROIC % -93.34
ROC (Joel Greenblatt) % -1367.36
ROCE % -19.93

Financials (Next Earnings Date:2022-08-16 Est.)

ATHA's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NAS:ATHA

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0
EPS (TTM) ($) -1.73
Beta 0
Volatility % 103.52
14-Day RSI 50.26
14-Day ATR ($) 0.273261
20-Day SMA ($) 3.5595
12-1 Month Momentum % -65.01
52-Week Range ($) 2.53 - 16.65
Shares Outstanding (Mil) 37.64

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 9999
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Athira Pharma Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More